Kudos to Dr. JunGao, Dr. Xheng & 🇨🇳 team on the ph 3 DV-tori vs platinum trial in mUC! Amazing to see alt options becoming available to bridge the global disparities for access. Tom Powles ESMO - Eur. Oncology Toni Choueiri, MD Andrea Necchi Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO Uromigos ウロミーゴズ

Very proud and happy to share that our work on neoadjuvant IO in pMMR colon cancers has been published online in nature after presentation ESMO - Eur. Oncology #ESMO25. Preview: rdcu.be/eLTN1 Read on how genomic instability, P53mt and proliferation may aid in predicting responses.

Are cancer surgeries removing the body’s secret weapon against cancer? New research reveals that lymph nodes, often removed during cancer surgery to prevent tumor spread, may actually be crucial for successful treatment. sciencedaily.com/releases/2025/…

Lymph nodes fuel KLF2-dependent effector CD8+ T cell differentiation during chronic infection and checkpoint blockade nature.com/articles/s4159…

Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity nature.com/articles/s4159…

Effect of Intensive Blood Pressure Control on Stroke: A Prespecified Secondary Analysis of the ESPRIT Trial Compared with targeting <140 mm Hg, targeting <120 mm Hg halved the risk of hemorrhagic stroke and did not increase that of ischemic stroke. #Cardiology #MedTwitter

Multimodality imaging in advanced heart failure. A clinical consensus statement of the Heart Failure Association of the ESC. Part 1: Multimodality imaging for the evaluation of patients with advanced heart failure The integration of these advanced imaging modalities enhances

Our paper led by Mamas A. Mamas et al ❤️‍🔥 Socioeconomic Deprivation, Diabetes & Post–Heart Attack Survival 🇬🇧 💡 People with diabetes in deprived areas face worse survival after heart attack ... but the inequality gap is greater in those without diabetes #Cardiology #Diabetes

📢 Semaglutide in non-overweight people with T2D 📊 Retrospective TriNetX study (BMI <25 kg/m²) 🩺 3-year outcomes •All-cause mortality: 6.1% vs 10.7% (HR 0.54, 95% CI 0.45–0.65) ✅ •AMI: NS •Stroke: NS •Adverse events: No significant difference 💡 Semaglutide associated

Post-hoc analysis of SYNERGY-NASH trial reveals key insights on #tirzepatide in #MASH patients ✅ MASH resolution linked to greater weight loss (-16% vs -7%) ✅ Fibrosis improvement associated with better glycemic control ✅ Liver fat normalization was key mediator of both

Using computational models to pinpoint safe and effective antimicrobial peptides is a real game-changer in tackling resistant microbes. Impressive 90% accuracy, a big step toward next-gen therapeutics! #Innovation #Biotech

New preprint 🔥 showing that blocking JAK1/2 with ruxolitinib boosts food intake, preserves fat, and extends survival in lung cancer–associated cachexia. Ezequiel Dantas biorxiv.org/content/10.110… #CancerMetabolism #Cachexia #LungCancer #JAKSTAT

September Spotlight: Major Moves in Melanoma From FDA approvals to long-term data, September brought pivotal melanoma updates—highlighting advances in subcutaneous immunotherapy and novel intralesional strategies. 🔗 Catch up on the month’s top stories: hubs.li/Q03PMzGK0

Measles is spreading is beyond the center of the Utah-Arizona outbreak. Cases are now occurring in the more touristy areas of Utah. nbcnews.com/health/health-…

“Just go and get a screening mammogram. Get it out of the way. It’s the putting it off and not getting screened where it becomes dangerous.” ctvnews.ca/health/article…

Spatial biology technologies are rapidly advancing, delivering unprecedented insights into cellular organization and disease pathology. Join our October 29th webinar on "Spatial Biology: Innovations & Applications" with a great lineup of speakers. Register via QR code

Canada’s healthcare draws vs. UAE’s talent programs-I see med professionals facing a real choice: which system will truly value and accelerate their expertise? Stability matters. So does innovation.

Join us on Thursday, November 6 for Bridging Perspectives in COVID's Wake. This event will bring together public health, science, and policy experts to discuss lessons that can strengthen our response to future public health challenges. Registration is free and a video

Fascinated by how bowhead whales resist cancer for 200+ years-thanks to CIRBP protein. UAE's biotech push excites me-could speed up breakthroughs in longevity.

I'm excited by how UAE's precision medicine investments could work with Canadian research strengths - together we could advance liquid biopsy trials faster. Strategic infrastructure makes all the difference.